AdvaMed® Comments to HHS Deregulation RFI

AdvaMed Comments to HHS Deregulation RFI

AdvaMed submitted public comments in response to HHS’s request for information on eliminating federal regulations that hinder economic growth, innovation, and American competitiveness. Our comprehensive proposals identify regulatory barriers that hinder innovation or patient care and advance regulatory relief from outdated, redundant and other regulations and processes detrimental to innovation and patient access.

Related Reading

News / Diagnostics / Digital Health / Government & Legislative Affairs / Regulatory Affairs

AdvaMed Statement on the Nomination of Dr. Heidi Overton as FDA Commissioner

August 19, 2026

WASHINGTON—Scott Whitaker, president and CEO of AdvaMed, the medtech association, made the following comment on President Trump’s nomination of Dr. Heidi Overton to serve as FDA commissioner.

Compliance

AdvaMed Code of Ethics Certification Directory

News / Government & Legislative Affairs / Regulatory Affairs / Small Business

AdvaMed Names Juan Carlos “JC” Scott Chief Strategy Officer and Executive Director of AdvaMed Accel

August 12, 2026

WASHINGTON, D.C. – AdvaMed today announced that Juan Carlos “JC” Scott has been appointed Chief Strategy Officer and Executive Director of AdvaMed Accel, a newly created leadership position focused on accelerating engagement with emerging medical technology companies and strengthening AdvaMed’s role at the center of the innovation ecosystem.

Resource / Government & Legislative Affairs

Scott Whitaker Op-Ed: Medtech: A great value in American health care

August 7, 2026

Medicare breakthrough medical technologies face delays between FDA authorization and coverage decisions, slowing patient access to innovation.

Event / AdvaMed Advancements / Business Development / Government & Legislative Affairs / Regulatory Affairs / Small Business

Medtech Showcase & Reception on Capitol Hill

September 16, 2026
5:00 PM – 7:00 PM

Experience the future of health care at the 2026 Medtech Showcase and Reception on Capitol Hill. Join AdvaMed® on September 16 for an interactive event featuring more than 25 medtech companies demonstrating breakthrough technologies that are transforming patient care. See innovative medical devices firsthand, connect with industry leaders and policymakers, and discover how medtech innovation is improving and saving lives.

News / Government & Legislative Affairs / Regulatory Affairs

AdvaMed Strongly Supports Draft MDUFA VI Agreement at FDA Public Meeting

August 5, 2026

WASHINGTON, D.C.—AdvaMed, the Medtech Association, today expressed strong support for the draft Medical Device User Fee Amendments (MDUFA) VI agreement at an FDA public hearing.

Resource / Coverage & Payment / Government & Legislative Affairs / Health Access

Gateways to Health: How Medtech Is Improving Care While Lowering Healthcare Costs

July 31, 2026

Read Gateways to Health, a special publication exploring how medical technology improves patient care, expands access, and lowers healthcare costs.

Resource / Compliance / Health Care Professionals – Commercial Sponsorships

AdvaMed® Device and Diagnostics Compliance Group Benchmarking | Commercial Sponsorships

July 30, 2026

Explore AdvaMed’s 2026 Commercial Sponsorships Benchmarking report, summarizing member compliance policies and industry trends across the medical technology sector.